Cauda Equina Syndrome in Neurosarcoidosis.

cauda equina immunosuppressive therapy neurosarcoidosis

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
27 Aug 2020
Historique:
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

Neurosarcoidosis (NS) is a mimicker of many infectious, neoplastic, and inflammatory diseases. It most commonly involves the cranial nerves followed by meninges, ventricles, hypothalamic-pituitary axis, spinal cord, and brainstem/cerebellum. While NS myelopathy has been increasingly recognized, pathophysiological/prognostic and management principles in NS-mediated cauda equina (CE) and conus medullaris (CM) syndromes, which constitute a small and rare minority of this subset, remain elusive. We present the case of a 49 -year-old Hispanic man who developed a peripheral facial palsy and primary hypogonadism within a span of 12 months and eventually got diagnosed with NS after he presented with CE syndrome. We also performed an extensive literature review, with a discussion on the underlying pathophysiology and current management recommendations for NS-mediated CE/CM syndrome. CE/CM syndromes in a middle-aged man should prompt the consideration of NS as a possible differential diagnosis. While steroid responsive, the majority of NS-CE/CM patients are left with residual neurodeficits with quick relapses when steroids are tapered, making the case for early institution of immunosuppressive therapies.

Identifiants

pubmed: 33005501
doi: 10.7759/cureus.10069
pmc: PMC7522054
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e10069

Informations de copyright

Copyright © 2020, Topiwala et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Muscle Nerve. 1999 May;22(5):608-13
pubmed: 10331360
JAMA Neurol. 2018 Dec 1;75(12):1546-1553
pubmed: 30167654
Neurology. 1965 Dec;15(12):1147-54
pubmed: 5893659
Paraplegia. 1996 Feb;34(2):116-20
pubmed: 8835038
South Med J. 1998 Sep;91(9):870-2
pubmed: 9743063
Neurologist. 2005 May;11(3):179-83
pubmed: 15860141
J Comput Tomogr. 1988 Apr;12(2):96-9
pubmed: 2844475
JAMA Neurol. 2017 Nov 1;74(11):1336-1344
pubmed: 29052709
Acta Radiol. 2001 Nov;42(6):563-7
pubmed: 11736702
Rev Rhum Mal Osteoartic. 1990 Dec;57(12):901-3
pubmed: 1964247
Sem Hop. 1972 Nov 14;48(46):3039-43
pubmed: 4347000
Surg Neurol. 1997 Nov;48(5):514-20; discussion 521
pubmed: 9352819
J Neurooncol. 1998 Sep;39(3):261-5
pubmed: 9821112
Neurosurgery. 1996 Jul;39(1):179-81
pubmed: 8805157
J Comput Assist Tomogr. 1989 Mar-Apr;13(2):364-5
pubmed: 2538495
J Neurol. 1990 Nov;237(7):424-6
pubmed: 2177103
BMC Neurol. 2016 Nov 15;16(1):220
pubmed: 27846819
Australas Radiol. 2003 Sep;47(3):295-7
pubmed: 12890252
J Neurol. 2000 Jul;247(7):573-4
pubmed: 10993507
J Neurosurg. 1977 Jul;47(1):109-12
pubmed: 864497

Auteurs

Karan Topiwala (K)

Neurology, Hartford Hospital, Hartford, USA.

Subhendu Rath (S)

Neurology, University of Michigan School of Medicine, Ann Arbor, USA.

Annie Daniel (A)

Neurology, Hartford Hospital, Hartford, USA.

Avinash Prasad (A)

Neurology, University of Connecticut School of Medicine, Hartford Hospital, Hartford, USA.

Classifications MeSH